低血糖
代谢紊乱
代谢性酸中毒
医学
酮症
儿科
彗差(光学)
复合杂合度
介绍(产科)
肉碱
内分泌学
内科学
疾病
生物
外科
胰岛素
糖尿病
基因
突变
生物化学
物理
光学
作者
Nassim Boutouchent,Julie Bourilhon,Bénédicte Sudrié‐Arnaud,Antoine Bonnevalle,Lucie Guyant‐Maréchal,Cécile Acquaviva,Loréna Dujardin-Ippolito,Soumeya Bekri,Ivana Dabaj,Abdellah Tebani
出处
期刊:Diagnostics
[Multidisciplinary Digital Publishing Institute]
日期:2021-08-28
卷期号:11 (9): 1561-1561
被引量:4
标识
DOI:10.3390/diagnostics11091561
摘要
3-Hydroxy-3-methylglutaryl-CoA (HMG-CoA) Lyase deficiency (HMGLD) (OMIM 246450) is an autosomal recessive genetic disorder caused by homozygous or compound heterozygous variants in the HMGCL gene located on 1p36.11. Clinically, this disorder is characterized by a life-threatening metabolic intoxication with a presentation including severe hypoglycemia without ketosis, metabolic acidosis, hyper-ammoniemia, hepatomegaly and a coma. HMGLD clinical onset is within the first few months of life after a symptomatic free period. In nonacute periods, the treatment is based on a protein- and fat-restricted diet. L-carnitine supplementation is recommended. A late onset presentation has been described in very few cases, and only two adult cases have been reported. The present work aims to describe an incidental discovery of an HMGLD case in a 54-year-old patient and reports a comprehensive review of clinical and biological features in adult patients to raise awareness about the late-onset presentation of this disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI